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We  analysed  the effects  of  oleanolic  acid (OA)  on  lung  mechanics  and  histology  and  its possible  mecha-
nisms  of  action  in experimental  acute  lung  injury  (ALI).  BALB/c  mice  were  randomly  divided  into  Control
(saline,  ip)  and  ALI  (paraquat,  25  mg/kg,  ip)  groups.  At 1  h,  both  groups  were  treated  with  saline (SAL, 50  l
ip), OA  (10  mg/kg  ip),  or dexamethasone  (DEXA,  1 mg/kg  ip). At  24 h, lung  static  elastance,  viscoelas-
tic  pressure,  and  alveolar  collapse  reduced  more  after  OA  compared  to  DEXA  administration.  Tumourhemokines
istopathology
ung mechanics
xidative stress
necrosis  factor-,  macrophage  migration  inhibitory  factor,  interleukin-6,  interferon-,  and  transforming
growth  factor-  mRNA  expressions  in  lung  tissue  diminished  similarly  after  OA  or DEXA.  Conversely,  only
OA avoided  reactive  oxygen  species  generation  and  yielded  a signiﬁcant  decrease  in  nitrite  concentra-
tion.  OA  and  DEXA  restored  the  reduced  glutathione/oxidized  glutathione  ratio  and  catalase  activity  while
increasing  glutathione  peroxidase  induced  by paraquat.  In conclusion,  OA  improved  lung  morphofunction
e  of inby  modulating  the  releas
. Introduction
Lung inﬂammation is a hallmark of acute lung injury (ALI) and
cute respiratory distress syndrome (ARDS). The response of cells
o lung inﬂammation may  lead to oxidant/antioxidant imbalance,
ith production of nitric oxide and superoxide and release of
ytotoxic and pro-inﬂammatory compounds, including proteolytic
nzymes, reactive oxygen species (ROS), reactive nitrogen species
RNS) and additional inﬂammatory cytokines, resulting in cellular
ysfunction (Chabot et al., 1998; Tasaka et al., 2008) and inhibition
f certain lung proteins. This oxidative injury perpetuates inﬂam-
ation and damages the alveolar-capillary membrane (Lee et al.,
010).Several pharmacological treatments have been tested to mod-
late the signalling pathways in order to decrease pulmonary
nﬂammation (Calfee and Matthay, 2007) and restore the oxi-
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dant/antioxidant balance (Chavko et al., 2009). So far, however,
an effective pharmacological therapy for ALI/ARDS has not been
identiﬁed. Recently, natural products derived from plant extracts
and their synthetic derivatives have been used to treat a wide
range of respiratory diseases due to their anti-inﬂammatory and
antioxidative properties. In this line, oleanolic acid (OA), a triter-
penoid compound present in a great variety of plants and food
products (Liu, 2005), modulates the production and activity of pro-
inﬂammatory cytokines and enzymatic antioxidant defence, as well
as protects from oxidant stress by activating Nrf2 (Reisman et al.,
2009; Takada et al., 2010; Wang et al., 2010). Chemical synthesis of
oleanolic acid has provided many useful derivatives that are more
potent and speciﬁc than natural parent structures (Honda et al.,
1997). Reddy et al. demonstrated that intermittent administration
of a synthetic triterpenoid compound, CDDO-imidazole (CDDO-
Im)  (1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl] imida-
zole, during exposure to hyperoxia confers protection against the
development of ALI in mice (Reddy et al., 2009). However, the
effects of oleanolic acid derivatives and triterpene derivatives are
Open access under the Elsevier OA license.not necessarily similar to those of their parent molecules (Honda
et al., 1998, 1999). Additionally, even though the biological activity
of oleanolic acid is lower than that of its derivatives, it is known to
be relatively non-toxic (Liu, 1995, 2005).
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We  tested the hypothesis that oleanolic acid may  curtail the
nﬂammatory process, improving lung morphology and function
n experimental ALI induced by paraquat.
. Materials and methods
This study was approved by the Health Sciences Centre Ethics
ommittee at the Federal University of Rio de Janeiro. All animals
eceived humane care in compliance with the “Principles of Labora-
ory Animal Care” formulated by the National Society for Medical
esearch and the “Guide for the Care and Use of Laboratory Ani-
als” prepared by the National Academy of Sciences, USA.
.1. Animal preparation and experimental protocol
One hundred and eight BALB/c male mice (20–25 g) were
ept under speciﬁc pathogen-free conditions in the Laboratory
f Pulmonary Investigation animal care facility. All animals were
andomly assigned to two groups. In the control group (C), mice
eceived saline intraperitoneally (50 L, ip), while in the ALI
roup paraquat (25 mg/kg, ip) was administered. Both groups were
urther treated with saline [ALI-SAL (0.1 mL,  ip)], oleanolic acid
ALI-OA (10 mg/kg, ip)]  or dexamethasone [ALI-DEXA (1 mg/kg, ip)]
Göcgeldi et al., 2008) 1 h after paraquat or saline injection, in ran-
omized order. For the present ALI model, different doses of OA
5, 10, and 20 mg/kg animal body weight) were titrated in pilot
tudies, and the 10 mg/kg dose was chosen based on the lowest
ortality rate and lung morphofunction impairment. Thirty-six
ice (n = 6/each) were used to evaluate lung mechanics and histol-
gy, as well as molecular biology. Forty-two animals (n = 7/each)
ere submitted to the same protocol described above to obtain
liquots of bronchoalveolar lavage ﬂuid (BALF). The remaining 30
nimals (n = 5/each) were used to evaluate the activity of antioxi-
ant enzymes, GSH/GSSG ratio and RNS.
.2. Lung mechanics
24 h after administration of paraquat or saline, the animals
ere sedated [diazepam (1 mg/kg, ip), anaesthetised [thiopental
odium (20 mg/kg, ip)], tracheotomised, paralysed (vecuronium
romide, 0.005 mg/kg, iv), and ventilated with a constant ﬂow ven-
ilator (Samay VR15; Universidad de la Republica, Montevideo,
ruguay) with the following parameters: respiratory frequency
f 100 breaths min−1, tidal volume (VT) of 0.2 mL,  and fraction of
nspired oxygen of 0.21. During spontaneous breathing, the level
f anaesthesia was assessed by evaluating the size and position
f the pupil, its response to light, the position of the nictitating
embrane, and the tone of jaw muscles. After muscle relaxation,
dequate depth of anaesthesia was assessed by evaluating pupil
ize and light reactivity (Correa et al., 2001).
A positive end-expiratory pressure (PEEP) of 2 cmH2O was
pplied and the anterior chest wall was surgically removed. After
 10-min ventilation period, lung static elastance (Est,L), resistive
P1,L) and viscoelastic (P2,L) pressures were measured by the
nd-inﬂation occlusion method (Bates et al., 1985). All data were
nalysed using the ANADAT data analysis software (RHT-InfoData,
nc., Montreal, Quebec, Canada). The duration of the lung mechanics
ata collection was 30 min  per animal.
.3. Histology
A laparotomy was done immediately after determination of lung
echanics, and heparin (1000 IU) was injected intravenously in the
ena cava. The trachea was clamped at end expiration, and the
bdominal aorta and vena cava were sectioned, yielding a mas-
ive haemorrhage that quickly killed the animals. The right lung Neurobiology 179 (2011) 129– 136
was ﬁxed with 10% buffered formaldehyde solution and paraf-
ﬁn embedded. Four-micrometre-thick slices (3/lung) were cut and
stained with haematoxylin-eosin. Lung morphometric analysis was
performed using an integrating eyepiece with a coherent system
consisting of a grid with 100 points and 50 lines (known length)
coupled to a conventional light microscope (Olympus BX51, Olym-
pus Latin America-Inc., Brazil). The volume fraction of the lung
occupied by collapsed alveoli (alveoli with rough or plicate walls)
or normal pulmonary areas, and the amount of polymorpho- and
mononuclear cells and pulmonary tissue were determined by the
point-counting technique (Weibel, 1990), made across 10 random
non-coincident microscopic ﬁelds at a magniﬁcation of 200× and
1000×, respectively.
2.4. Cytokine mRNA expression using ribonuclease protection
assay
Four animals in each group were used for determination of
cytokine mRNA expression by using ribonuclease protection assay
(RPA).
The in vitro transcription kit and a customized template set
[containing mouse tumour necrosis factor (TNF)-,  interleukin (IL)-
6, interferon (IFN)-,  transforming growth factor (TGF)-1, the
housekeeping gene glyceraldehyde-3-phosphate-dehydrogenase
(GAPDH), and L32 (ribosomal RNA)] were used to synthesize a
radiolabeled probe set using [-32P]UTP. Each speciﬁc hybridized
product migrates according to its size, thereby allowing identiﬁ-
cation of individual bands that were assigned to speciﬁc mRNA
products. After RNAse treatment and puriﬁcation, protected probes
were run on a sequence gel, exposed to X-ray ﬁlms, and devel-
oped. The quantity of each mRNA species in the original RNA
sample was determined on the basis of the signal intensity
(by optical densitometry) given by the appropriately sized, pro-
tected probe fragment band. Density of each cytokine mRNA was
expressed relative to that of the housekeeping gene GAPDH. These
values were then related to control group (Leite-Junior et al.,
2008).
2.5. Evaluation of bronchoalveolar lavage ﬂuid
In 42 additional animals (n = 7/each) reactive oxygen species
(ROS) were measured in leukocytes recovered in bronchoalveo-
lar lavage ﬂuid with a ﬂow cytometry assay. For this purpose, a
polyethylene cannula was  inserted into the trachea and a total
volume of 1.5 mL  of buffered saline (PBS) containing 10 mM EDTA
was instilled and aspirated three times. The bronchoalveolar lavage
ﬂuid was centrifuged, and the pellet containing leukocytes was
resuspended in PBS. ROS were measured using a ﬂuorescent
probe dissolved in DMSO and re-suspended in PBS to a ﬁnal
concentration of 20 M.  Flow cytometry was used to measure
intracellular ﬂuorescence. To measure ROS generation, H2DCF-DA
(2,7-dichlorodihydroﬂuorescein diacetate from molecular probes)
was used. The ﬂuorescence was  measured at the ﬂuorescent (FL)1
channel and the results were expressed as the mean of ﬂuorescence
intensity (MFI) (Ka et al., 2003).
2.6. Lung tissue analyses
2.6.1. Protein content
In the last set of animals, lungs were homogenized (Homog-
enizer Nova Tecnica mod  NT 136, Piracicaba, Brazil) in 1.0 mL
potassium phosphate buffer (pH 7.5), centrifuged at 3000 × g (cen-
trifuge FANEM mod  243 M,  Sao Paulo, Brazil) for 10 min, and
supernatants were collected for biochemical analysis. Protein con-
centration was estimated by Bradford’s protocol, using bovine
serum albumin as a standard (Bradford, 1976).
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Fig. 1. (A) Est,L = lung static elastance, and (B) P1,L = lung resistive pressure and
P2,L  = lung viscoelastic/inhomogeneous pressure. In control (C) animals, saline
was intraperitoneally (50 L, ip)  injected. In ALI group, mice received paraquat
(25 mg/kg, ip). In ALI-SAL, ALI-DEXA, and ALI-OA, animals were treated with saline
(0.1 mL,  ip), dexamethasone (1 mg/kg, ip), and oleanolic acid (10 mg/kg, ip), respec-
tively, 1 h after the induction of lung injury. Values are means + SEM of 6 animals in
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.6.2. Nitrite assay
Nitrite (NO2−), a by-product of nitric oxide metabolism, was
easured with the Griess reaction (Valenc¸ a et al., 2009). Sam-
les of lung homogenates (100 L) were reacted with 50 L of 1%
ulphanilamide solution for 10 min  and mixed with 50 L of 0.1%
aphthyl ethylenediamine solution. Formation of the purple azo
ompound was measured spectrophotometrically by absorbance
t 540 nm.  The method was standardized with increasing concen-
rations of nitrite, which were expressed as mol/mg protein.
.6.3. Reduced glutathione (GSH) and glutathione disulﬁde
GSSG) assay
This assay was based on the reaction of GSH or GSSG with
,5-dithiobis-(2-nitrobenzoic acid) (DTNB), which produces the 2-
itro-5-thiobenzoate (TNB) chromophore (Rahman et al., 2006). To
etermine GSSG, lung homogenate samples were treated with 2-
inylpyridine, which covalently reacted with GSH (but not GSSG).
he excess 2-vinylpyridine was neutralized with triethanolamine.
he rate of formation of TNB, measured spectrophotometrically by
bsorbance at 412 nm,  is proportional to the concentration of GSH
r GSSG in the sample. The concentration of an unknown sample
as determined based on linear equation or the regression curve
enerated by several standards of GSH or GSSG. The ﬁnal result was
resented as GSH (nmol/mg protein), GSSG (nmol/mg protein), and
SH/GSSG ratio.
.6.4. Activity of catalase (CAT) and glutathione peroxidase (GPx)
CAT and GPx activities were determined in lung homogenates.
AT activity was measured by the rate of decrease in hydrogen
eroxide concentration at 240 nm (Aebi, 1984). GPx activity was
easured by monitoring the oxidation of NADPH at 340 nm in the
resence of H2O2 (Flohé and Günzler, 1984).
.7. Statistical analysis
The normality of the data (Kolmogorov-Smirnov test with Lil-
iefors’ correction) and the homogeneity of variances (Levene
edian test) were tested. Since no signiﬁcant differences were
bserved between the control groups, only one control group was
onsidered. Thus, differences among the groups were assessed by
ne-way ANOVA followed by Tukey’s test. Survival rates were com-
ared by the log-rank test. Correlations between lung mechanical
nd morphometric parameters were evaluated using Spearman’s
orrelation test. A p value < 0.05 was considered signiﬁcant. Data
re presented as mean + SEM. The SigmaStat 3.1 statistical software
ackage (Jandel Corporation, San Raphael, CA, USA) was used.
. ResultsSurvival rate was lower in the ALI-SAL group (60%) compared to
he Control group (100%) (p < 0.001) and increased in ALI-OA and
LI-DEXA (85%) as compared to ALI-SAL (p < 0.05).
able 1
ung morphometry.
GROUP Normal (%) Alveolar collapse (%) 
Control 93.5 ± 1.0 6.5 ± 1.0 
ALI
SAL 38.8 ±  3.4* 61.2 ± 4.1*
DEXA  82.9 ± 2.1*,** 17.1 ± 1.5*,**
OA  86.3 ± 1.1*,** ,# 13.7 ± 0.9*,** ,#
alues are means (±SEM) of 6 animals in each group. All values were computed in ten ra
otal  cells, neutrophils, and MN (mononuclear cells). In Control animals, saline was intrap
p).  In ALI-SAL, ALI-DEXA, and ALI-OA, animals were treated with saline (0.1 mL,  ip), dexam
nduction of lung injury.
* Signiﬁcantly different from Control group (p < 0.05).
** Signiﬁcantly different from ALI-SAL group (p < 0.05).
# Signiﬁcantly different from ALI-DEXA group (p < 0.05).each  group. *Signiﬁcantly different from C group (p < 0.05). **Signiﬁcantly different
from ALI-SAL group (p < 0.05).
Est,L and P2,L were signiﬁcantly higher in ALI-SAL com-
pared to the Control group (Fig. 1A and B). Mechanical parameters
improved after administration of both OA and DEXA, but only the
ALI-OA group reached Control levels. No changes occurred in P1,L
after induction of ALI or treatment.
The fraction area of alveolar collapse, total cells and neutrophils
was higher in ALI-SAL compared to the Control group (Table 1). The
fraction area of alveolar collapse was reduced in ALI-OA and ALI-
DEXA, but this reduction was  more effective in the ALI-OA group.
Total cells (%) Neutrophils (%) MN (%)
36.7 ± 1.1 0.3 ± 0.1 36.1 ± 1.1
43.4 ± 1.0* 7.5 ± 0.4* 35.9 ± 1.0
37.7 ± 1.8 1.9 ± 0.1*,** 35.8 ± 1.8
37.7 ± 0.8 2.1 ± 0.3*,** 35.5 ± 0.9
ndom, non-coincident ﬁelds per mice. Fraction areas of normal, collapsed alveoli,
eritoneally (50 L, ip) injected. In the ALI group, mice received paraquat (25 mg/kg,
ethasone (1 mg/kg, ip), and oleanolic acid (10 mg/kg, ip), respectively, 1 h after the
132 R.S. Santos et al. / Respiratory Physiology & Neurobiology 179 (2011) 129– 136
Fig. 2. Photomicrographs of lung parenchyma stained with haematoxylin-eosin. (A) control, (B) ALI-SAL, (C) ALI-DEXA, and (D) ALI-OA groups. In control (C) animals, saline
was  intraperitoneally (50 L, ip) injected. In acute lung injury (ALI) group, mice received paraquat (25 mg/kg, ip). In ALI-SAL, ALI-DEXA, and ALI-OA, animals were treated
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 similar decrease was observed in total cell count and neutrophils
fter OA or DEXA administration (Table 1 and Fig. 2).
Considering all groups, Est,L and P2,L were signiﬁcantly corre-
ated with total cell count [r = 0.80 (p < 0.001) and r = 0.60 (p < 0.016),
espectively], and alveolar collapse [r = 0.88 (p < 0.001) and r = 0.70
p < 0.003), respectively].
TNF-, MIF, IL−6, IFN-, TGF- mRNA expressions were higher
n ALI-SAL compared to the Control group. OA and DEXA admin-
stration minimized these changes with no signiﬁcant differences
etween these therapies (Fig. 3).
In the ALI-SAL group, the MFI  of ROS increased signiﬁcantly com-
ared to the Control group. OA prevented ROS generation more
ffectively than DEXA (Fig. 4).
Nitrite generation increased in ALI-SAL compared to the Control
roup. In ALI-OA, but not in ALI-DEXA group, nitrite concentration
igniﬁcantly decreased compared to ALI-SAL (Fig. 5).
As shown in Fig. 6, there was a reduction in GSH/GSSG ratio
n ALI-SAL compared to the Control group. GSH/GSSG ratio was
estored in the ALI-DEXA and ALI-OA groups (Fig. 6A). The activity
f glutathione peroxidase (GPx) was reduced in ALI-SAL com-
ared to the Control group. After DEXA treatment, there was  an
ncrease in GPx activity compared to ALI-SAL, but Control levels
ere not reached. GPx activity was highest after OA administra-
ion (Fig. 6B). The activity of catalase (CAT) was elevated in ALI-SAL
ompared to the Control group. DEXA and OA treatments caused a
ecrease in CAT activity compared to the ALI-SAL group. Neverthe-
ess, CAT activity returned to Control levels only after OA therapy
Fig. 6C).spectively, 1 h after the induction of lung injury. Scale bar = 100 m.
4.  Discussion
In the present study, intraperitoneal administration of oleano-
lic acid 1 h after paraquat-induced acute lung injury (1) reduced
alveolar collapse and neutrophil inﬁltration, improving lung
mechanics, (2) modulated the inﬂammatory process, diminishing
pro-inﬂammatory cytokines, (3) avoided reactive oxygen species
generation and led to a signiﬁcant decrease in nitrite concentra-
tion, (4) modulated the activity of antioxidant enzymes, such as
glutathione peroxidase and catalase, and (5) restored GSH/GSSG
ratio.
To the best of our knowledge, this is the ﬁrst study inves-
tigating the effects of OA in an experimental model of ALI. We
used an ALI model induced by paraquat, which is an herbicide
that accumulates predominantly in the lung, causing damage to
type I and II pneumocytes, pulmonary oedema and inﬁltration of
inﬂammatory cells (Rocco et al., 2004). Paraquat promotes oxi-
dant/antioxidant imbalance through generation of the superoxide
anion, which can lead to the formation of more toxic ROS and
oxidation of the cellular NADPH, causing disruption of important
NADPH-requiring biochemical processes and lipid peroxidation
(Suntres, 2002). Furthermore, paraquat itself induces intracellular
transcription factors such as nuclear factor (NF)-B and activa-
tor protein-1. NF-B leads to transcriptional activation of many
pro-inﬂammatory genes, including iNOS, several cytokines, and
cyclooxygenase-2 (COX-2), all of which exaggerate the inﬂamma-
tory process. In the present study, we  chose speciﬁc mediators that
are involved in inﬂammatory and ﬁbrogenic processes in paraquat-
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njury.  *Signiﬁcantly different from C group (p < 0.05). **Signiﬁcantly different from
nduced acute lung injury, that is, TNF-, MIF, IL-6, IFN-, and TGF-
Rocco et al., 2004).
Long-term use of a low or moderate dose of OA is relatively non-
oxic and safe (Liu, 1995, 2005). The effects of OA were compared
ith those of an established anti-inﬂammatory agent, the glucocor-
icoid dexamethasone at 1 mg/kg (Göcgeldi et al., 2008; Carvalho
t al., 2010).
Dexamethasone was used because intraperitoneal absorption
f this steroid is more effective than that of other steroids; thus,
t is especially adequate for comparison with OA administered
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ig. 4. MFI  = mean of ﬂuorescence intensity of ROS in bronchoalveolar lavage ﬂuid.
n  control (C) animals, saline was intraperitoneally (50 L, ip) injected. In the ALI
roup, mice received paraquat (25 mg/kg, ip). In ALI-SAL, ALI-DEXA, and ALI-OA,
nimals were treated with saline (0.1 mL,  ip), dexamethasone (1 mg/kg, ip), and
leanolic acid (10 mg/kg, ip), respectively, 1 h after induction of lung injury. Values
re means + SEM of 7 animals in each group. *Signiﬁcantly different from C group
p  < 0.05). **Signiﬁcantly different from ALI-SAL group (p < 0.05). #Signiﬁcantly dif-
erent from ALI-DEXA group (p < 0.05). L, ip) injected. In the ALI group, mice received paraquat (25 mg/kg, ip).  In ALI-SAL,
g/kg, ip), and oleanolic acid (10 mg/kg, ip),  respectively, 1 h after induction of lung
AL group (p < 0.05).
intraperitoneally (Engelhardt, 1987). In addition, as a corticosteroid
it inhibits NF-B and activator protein-1, blocks NF-B-dependent
proinﬂammatory gene expression and the transcription of several
cytokines relevant to ALI/ARDS pathology (Jantz and Sahn, 1999),
as well as increases intracellular GSH under oxidative stress in
alveolar epithelial cells (Rahman et al., 1998). Since the use of cor-
ticosteroids has not translated into decreased mortality rates in
ALI/ARDS (Diaz et al., 2010), an effort to develop therapeutic agents
that act on other inﬂammatory mechanisms, such as antioxidant
activity, is warranted.
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Fig. 5. Nitrite concentration in lung tissue. In control (C) animals, saline was
intraperitoneally (50 L, ip) injected. In ALI, mice received paraquat (25 mg/kg, ip).
In ALI-SAL, ALI-DEXA, and ALI-OA, animals were treated with saline (0.1 mL,  ip), dex-
amethasone (1 mg/kg, ip), and oleanolic acid (10 mg/kg, ip),  respectively, 1 h after
induction of lung injury. Values are means + SEM of 5 animals in each group. *Signif-
icantly different from C group (p < 0.05). **Signiﬁcantly different from ALI-SAL group
(p  < 0.05).
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In the present study, OA acted on the inﬂammatory process
y reducing generation of pro-inﬂammatory cytokines (Fig. 3),
OS, and nitrite, as well as by upregulating antioxidant enzymes
Figs. 4–6). Anti-inﬂammatory effects of OA have been reported
Nataraju et al., 2009; Martín et al., 2010) and associated with inhi-
ition of NF-B (Takada et al., 2010). This, in turn, has been observed
o yield a reduction in inﬂammatory cytokines and apoptotic cells,
s well as nitrite overproduction, with subsequent maintenance of
ntracellular GSH level (Abdel-Zaher et al., 2007).
Additionally, recent studies have suggested that OA modulates
SH, CAT and GPx activities (Ovesná et al., 2004; Tsai and Yin,
008; Wang et al., 2010) and exhibits potent scavenging behaviour,
ith a quenching effect on superoxide anion radicals, prevent-
ng redox imbalance and formation of oxidant radicals (Yin and
han, 2007). It has been proposed that OA may  play an antioxi-
ant role through inhibition of the release of high mobility group
ox-1 protein (HMGB1) (Kawahara et al., 2009) and the activation
f Nrf2, a transcriptional factor that induces antioxidant-response
lements (Reisman et al., 2009; Wang et al., 2010). A recent study
as reported that the targeting of Nrf2 with oleanolic acid deriva-
ive may  provide an effective therapy to limit the potential adverse
ffects of hyperoxia (Reddy et al., 2009). However, so far, no study
as analysed the impact of oleanolic acid in paraquat induced
xperimental acute lung injury.Therefore, the protective effects of OA against ROS in the present
araquat-induced ALI could be associated with a restoration of
SH/GSSG ratio. GSH is a nonprotein thiol that may  provide intra-
ellular protection against the oxidative action of paraquat (Tasakals were treated with saline (0.1 mL,  ip), dexamethasone (1 mg/kg, ip), and oleanolic
 + SEM of 5 animals in each group. *Signiﬁcantly different from C group (p < 0.05).
EXA group (p < 0.05).
et al., 2008), and also modulate the activity of catalase and GPx
(Fig. 6). Furthermore, OA may  protect against oxidative stress
through iNOS inhibition (Suh et al., 1998), preventing the increase
in nitrite, since excessive production of nitric oxide contributes to
the pathogenesis of ALI (Lange et al., 2010).
Lung viscoelastic/inhomogeneous pressure and static elastance
increased in the ALI-SAL group (Fig. 1A and B) due to alveolar
collapse, oedema, and inﬂammatory cell inﬁltration (Table 1 and
Fig. 2). In the present model, morphofunctional changes were
reduced by both DEXA and OA, but these beneﬁcial effects were
more intense after OA administration. The mechanical improve-
ment in the OA group was related to a greater reduction in the
inﬂammatory process, which led to less alveolar collapse and
oedema. OA and DEXA reduced inﬂammatory cytokines to a similar
degree. However, OA was  more effective than DEXA in modulating
oxidative stress and regulating the release of nitrite and antioxidant
enzymes, such as catalase and glutathione peroxidase. This advan-
tage may be related to the ability of OA to activate nuclear factor
E2-related factor 2 (Nrf2) and MAP  kinases (JNK and ERK) (Wang
et al., 2010), while the main role of DEXA is to downregulate NF-B
and AP1 (Meduri et al., 2009).
This study has some limitations that need to be addressed: (1)
a speciﬁc experimental model of paraquat induced ALI was used.
Therefore, the present results may  not be extended to other exper-
imental models of ALI, (2) animals were mechanically ventilated
in air, and thus we  cannot rule out that the increase in inﬂamma-
tory mediators in ALI-SAL may  be related, at least in part, to hypoxia
resulting from a greater amount of atelectasis, and/or that different
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esults could have been obtained with higher FiO2, (3) OA was not
ompared with a ROS inhibitor but with dexamethasone which has
een used in the clinical setting. Thus, we cannot rule out different
ffects with other types of steroids, different doses and routes of
dministration, (4) a single intraperitoneal dose of OA was  admin-
stered, and consequently, we cannot exclude the possibility that
ultiple doses or continuous infusion could yield better results.
he methods to quantify OA in plasma, and the optimal range and
oute of OA administration in humans are currently being deﬁned
Song et al., 2006; Ji et al., 2009). Even though OA might be safely
dministered in humans, the optimal oral or intravenous dosage
nder different clinical conditions remains to be determined, (5)
A was given 1 h after the induction of lung injury, and therefore,
he effect of OA at a later phase of ALI is unknown, and (6) OA,
ut not its derivatives, was used in the current study, thus we can-
ot exclude that different results could be obtained, and (7) only a
imited number of cytokines were investigated, mainly related to
nﬂammatory and ﬁbrogenic processes in paraquat- induced ALI.
In conclusion, intraperitoneal injection of oleanolic acid 1 h after
he induction of paraquat-induced acute lung injury modulated the
nﬂammatory and oxidative processes, preventing lung mechan-
cal and histological changes. Thus, oleanolic acid, a drug with
nti-inﬂammatory and anti-oxidative properties, may  be a useful
djunct therapy for acute lung injury.
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